Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase.

Rawson JM, Roth ME, Xie J, Daly MB, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM.

Bioorg Med Chem. 2016 Jun 1;24(11):2410-22. doi: 10.1016/j.bmc.2016.03.052. Epub 2016 Mar 30.

PMID:
27117260
2.

Dual anti-HIV mechanism of clofarabine.

Daly MB, Roth ME, Bonnac L, Maldonado JO, Xie J, Clouser CL, Patterson SE, Kim B, Mansky LM.

Retrovirology. 2016 Mar 24;13:20. doi: 10.1186/s12977-016-0254-0.

3.

5-Azacytidine Enhances the Mutagenesis of HIV-1 by Reduction to 5-Aza-2'-Deoxycytidine.

Rawson JM, Daly MB, Xie J, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2318-25. doi: 10.1128/AAC.03084-15. Print 2016 Apr.

4.

Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector.

Rawson JM, Clouser CL, Mansky LM.

Methods Mol Biol. 2016;1354:71-88. doi: 10.1007/978-1-4939-3046-3_6.

PMID:
26714706
5.

Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs.

Clouser CL, Bonnac L, Mansky LM, Patterson SE.

Antivir Chem Chemother. 2014 Dec 16;23(6):223-30. doi: 10.3851/IMP2682.

6.

Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine.

Clouser CL, Chauhan J, Bess MA, van Oploo JL, Zhou D, Dimick-Gray S, Mansky LM, Patterson SE.

Bioorg Med Chem Lett. 2012 Nov 1;22(21):6642-6. doi: 10.1016/j.bmcl.2012.08.108. Epub 2012 Sep 6.

7.

Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.

Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, O'Sullivan MG, Patterson SE, Mansky LM.

Antimicrob Agents Chemother. 2012 Apr;56(4):1942-8. doi: 10.1128/AAC.06161-11. Epub 2012 Jan 23.

8.

Discovery of drugs that possess activity against feline leukemia virus.

Greggs WM 3rd, Clouser CL, Patterson SE, Mansky LM.

J Gen Virol. 2012 Apr;93(Pt 4):900-5. doi: 10.1099/vir.0.039909-0. Epub 2012 Jan 18.

9.

Broadening the use of antiretroviral therapy: the case for feline leukemia virus.

Greggs WM 3rd, Clouser CL, Patterson SE, Mansky LM.

Ther Clin Risk Manag. 2011;7:115-22. doi: 10.2147/TCRM.S17731. Epub 2011 Mar 16.

10.

Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine.

Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, Chauhan J, VanHoutan IM, Patterson SE, Mansky LM.

PLoS One. 2011 Jan 14;6(1):e15840. doi: 10.1371/journal.pone.0015840.

11.

The role of Rab5a GTPase in endocytosis and post-endocytic trafficking of the hCG-human luteinizing hormone receptor complex.

Gulappa T, Clouser CL, Menon KM.

Cell Mol Life Sci. 2011 Aug;68(16):2785-95. doi: 10.1007/s00018-010-0594-1. Epub 2010 Nov 23.

12.

Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms.

Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS.

J Virol. 2011 Jan;85(1):43-50. doi: 10.1128/JVI.01774-10. Epub 2010 Oct 20.

13.

Exploiting drug repositioning for discovery of a novel HIV combination therapy.

Clouser CL, Patterson SE, Mansky LM.

J Virol. 2010 Sep;84(18):9301-9. doi: 10.1128/JVI.01006-10. Epub 2010 Jul 7.

14.

5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1.

Dapp MJ, Clouser CL, Patterson S, Mansky LM.

J Virol. 2009 Nov;83(22):11950-8. doi: 10.1128/JVI.01406-09. Epub 2009 Sep 2.

15.

Gonadotropin receptors: role of post-translational modifications and post-transcriptional regulation.

Menon KM, Clouser CL, Nair AK.

Endocrine. 2005 Apr;26(3):249-57. Review.

PMID:
16034179
16.

N-linked glycosylation facilitates processing and cell surface expression of rat luteinizing hormone receptor.

Clouser CL, Menon KM.

Mol Cell Endocrinol. 2005 May 12;235(1-2):11-9. Epub 2005 Mar 25.

PMID:
15866423
17.

Evidence that palmitoylation of carboxyl terminus cysteine residues of the human luteinizing hormone receptor regulates postendocytic processing.

Munshi UM, Clouser CL, Peegel H, Menon KM.

Mol Endocrinol. 2005 Mar;19(3):749-58. Epub 2004 Nov 11.

PMID:
15539429
18.

Regulation of luteinizing hormone/human chorionic gonadotropin receptor expression: a perspective.

Menon KM, Munshi UM, Clouser CL, Nair AK.

Biol Reprod. 2004 Apr;70(4):861-6. Epub 2003 Dec 10. Review.

PMID:
14668203

Supplemental Content

Loading ...
Support Center